Cryoretinopexy for proliferative diabetic retinopathy

Area of Science:

• Ophthalmology
• Diabetic Retinopathy Management

Background:

• Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss.
• Neovascularization in PDR requires effective management strategies.

Purpose of the Study:

• To evaluate the efficacy and safety of cryoretinopexy in managing PDR.
• To compare transconjunctival and transscleral cryoretinopexy techniques.

Main Methods:

• Retrospective analysis of patients with PDR treated with transconjunctival cryoretinopexy (6 eyes) or transscleral cryoablation (14 eyes).
• Assessment of neovascularization regression and visual acuity changes.
• Documentation of treatment-related complications.

Main Results:

• Transconjunctival cryoretinopexy resulted in neovascularization regression in only 1 of 6 eyes, with vision improvement in 2 eyes.
• Transscleral cryoablation achieved regression in 5 posterior and 2 anterior segment neovascularizations, but vision decreased in 9 eyes.
• Transconjunctival therapy had no complications, while transscleral therapy caused uveitis (14 eyes), vitreous hemorrhage (2 eyes), and traction retinal detachment (5 eyes).

Conclusions:

• Transconjunctival cryoretinopexy demonstrates limited effectiveness for PDR neovascularization.
• Transscleral cryoablation is associated with significant complications and visual morbidity.
• Further research is needed to establish the risk/benefit profile of cryoablation for PDR.